|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.40 CNY | +2.35% |
|
+20.86% | +75.88% |
| 05-28 | Chinese Stocks Muted Over Uncertainties Surrounding Tariff War Pause | MT |
| 05-28 | Salubris Pharmaceuticals to Buy Rights for Hypertension Drug; Shares Down 3% | MT |
| Capitalization | 60.65B 8.45B 7.25B 6.75B 6.28B 11.59B 728B 12.94B 81.58B 30.8B 341B 31.69B 31.03B 1,254B | P/E ratio 2025 * |
89.2x | P/E ratio 2026 * | 75.6x |
|---|---|---|---|---|---|
| Enterprise value | 60.65B 8.45B 7.25B 6.75B 6.28B 11.59B 728B 12.94B 81.58B 30.8B 341B 31.69B 31.03B 1,254B | EV / Sales 2025 * |
13.4x | EV / Sales 2026 * | 11.2x |
| Free-Float |
37.38% | Yield 2025 * |
0.99% | Yield 2026 * | 1.08% |
More valuation ratios
* Estimated data
More news
| 1 day | +2.35% | ||
| 1 week | +20.86% | ||
| Current month | +14.94% | ||
| 1 month | +11.43% | ||
| 3 months | +50.90% | ||
| 6 months | +79.36% | ||
| Current year | +75.88% |
| 1 week | 44.65 |  | 55.48 |
| 1 month | 44.5 | | 55.48 |
| Current year | 27.66 | | 55.48 |
| 1 year | 27.51 | | 55.48 |
| 3 years | 22.3 | | 55.48 |
| 5 years | 20 | | 55.48 |
| 10 years | 16.7 | | 55.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 52 | 2022-09-22 |
Yun Kong
DFI | Director of Finance/CFO | 52 | 2021-12-29 |
Jian Feng Yang
ADM | Chief Administrative Officer | 49 | 2005-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Hai Ye
CHM | Chairman | 81 | 1998-11-02 |
Sing Ye
CHM | Chairman | 51 | 2022-09-22 |
Jian Feng Yang
BRD | Director/Board Member | 49 | 2010-08-19 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.63% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.35% | +20.86% | +91.35% | +113.84% | 8.45B | ||
| -0.58% | +1.29% | +6.23% | +91.84% | 47.18B | ||
| +1.85% | +2.53% | +33.02% | - | 24.65B | ||
| -1.20% | -1.63% | -10.16% | +33.84% | 23.41B | ||
| -0.01% | -0.18% | -1.62% | +53.23% | 13.9B | ||
| -0.79% | -0.47% | -17.77% | +172.14% | 11.39B | ||
| -0.05% | +2.04% | +57.46% | +483.43% | 7.29B | ||
| 0.00% | +0.25% | +34.01% | +100.60% | 7.09B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| Average | +0.16% | +2.13% | +24.07% | +149.85% | 15.59B | |
| Weighted average by Cap. | +0.00% | +1.59% | +14.49% | +109.73% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.53B 631M 541M 504M 469M 865M 54.3B 966M 6.09B 2.3B 25.46B 2.37B 2.32B 93.59B | 5.43B 756M 649M 605M 562M 1.04B 65.12B 1.16B 7.3B 2.76B 30.53B 2.84B 2.78B 112B |
| Net income | 675M 94.06M 80.7M 75.19M 69.96M 129M 8.1B 144M 908M 343M 3.8B 353M 345M 13.96B | 790M 110M 94.42M 87.97M 81.85M 151M 9.48B 169M 1.06B 401M 4.44B 413M 404M 16.33B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
3,596
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 54.40 ¥ | +2.35% | 16,630,840 |
| 25-07-17 | 53.15 ¥ | +10.00% | 16,764,360 |
| 25-07-16 | 48.32 ¥ | +4.36% | 15,995,750 |
| 25-07-15 | 46.30 ¥ | +1.94% | 9,780,295 |
| 25-07-14 | 45.42 ¥ | +0.91% | 6,853,300 |
End-of-day quote Shenzhen S.E., July 17, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
54.40CNY
Average target price
43.14CNY
Spread / Average Target
-20.71%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002294 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition